Interests: Cervical Cancer; Ovarian Cancer; Endometrial Cancer; Vulvar Cancer
Special Issue Information
Gynecological tumors are solid tumors happened in the reproductive system of women, including ovarian, cervical cancer, endometrial cancer and others. These cancers seriously affect the health of women worldwide, and contributing considerably to the global cancer burden. Many conventional anticancer drugs have been used for gynaecological tumors. For example, cisplatin, paclitaxel, methotrexate, vinorelbine and gemcitabine are often used for the treatment of gynaecological tumors. However, they may lack therapeutic effects or cause cytotoxic effects. In addition, there are many reports of gynaecological cancer progression and recurrence due to cancer cells that resist to treatments.
Significant progress has been made in the treatment of gynecological tumors in recent years. Molecular targeted therapies have emerged as clinically useful drugs for the cure of gynaecological tumors. Molecular mechanisms of carcinogenesis and recurrence of gynecological cancers are gaining better understanding due to recent advances in molecular biology and genomic research. However, there remains a need to uncover biomarkers for prognosis and predictive diagnosis, progression and recurrence of gynecological tumors, and challenges for new therapeutics remain.
In this topic, we welcome articles for the molecular and cellular biology, biomarkers, diagnostics, and the treatment of gynaecological tumors including conventional chemotherapy, small molecular targeted drugs and monoclonal antibodies for targeted therapy. In addition, new technologies such as liquid biopsy, mRNA vaccines and gemonic editing therapy focused on gynecological tumors are also welcome.
Prof. Zhe-Sheng (Jason) Chen
Manuscript Submission Information
Manuscripts should be submitted online at https://ejgo.imrpress.combyregisteringandlogging into this website. Once you are registered,click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on theInstructions for Authorspage. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.